GILEAD SCIENCES, INC. 4

Gilead Sciences EVP & General Counsel Keeley M. Cain Wettan had 590 RSUs vest into common stock and 285 shares withheld for taxes on September 10, 2026.

On September 10, 2026, Gilead Sciences, Inc. EVP, General Counsel, Legal & Compliance Keeley M. Cain Wettan had 590 restricted stock units vest and convert into an equivalent number of common shares, increasing her direct common stock holdings to 9,044 shares. In connection with this vesting, 285 shares of common stock were automatically withheld by the issuer at a price of $144.81 per share to cover tax obligations, reducing her directly held common stock to 8,759 shares. Following these transactions, she directly owns 8,759 shares of Gilead common stock, in addition to any remaining unvested RSUs, with the RSUs subject to a four-year vesting schedule where 25% vest on the first anniversary of the grant date and the remaining balance vests 6.25% quarterly until fully vested.

Filing Facts

CIK

882095

Ticker

GILD

Form

4

Source Type

fda

Accession

0002110603-26-000013

Alert Tier

7